Kobe Steel to Take Equity Share in US Secondary Processor

Kobe Steel plans to take an equity stake in the US secondary steel processor, Grand Blanc Processing LLC.

They are making this move to position themselves such that they will be able to strengthen their ability to supply wire rod to the US automotive industry.

Grand Blanc is currently 100% owned by Shinsho Corp, a Kobe Steel Affiliate. In March, Kobe will take a 20% stake in Grand Blanc, while secondary processors Meihoku Kogyo and Osaka Seiko (who each have business links with Kobe) will both take a 5% share, with Shinsho holding the balance.

Grand Blanc sources wire rod from numerous suppliers. They heat treat the rod and draw it down into wires for use in nuts and bolts for the automotive industry.

For more information on steel manufacture, click here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kobe Steel. (2019, March 19). Kobe Steel to Take Equity Share in US Secondary Processor. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=414.

  • MLA

    Kobe Steel. "Kobe Steel to Take Equity Share in US Secondary Processor". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=414>.

  • Chicago

    Kobe Steel. "Kobe Steel to Take Equity Share in US Secondary Processor". AZoM. https://www.azom.com/news.aspx?newsID=414. (accessed November 21, 2024).

  • Harvard

    Kobe Steel. 2019. Kobe Steel to Take Equity Share in US Secondary Processor. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=414.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.